1. Home
  2. SCOR vs OKYO Comparison

SCOR vs OKYO Comparison

Compare SCOR & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo comScore Inc.

SCOR

comScore Inc.

HOLD

Current Price

$7.51

Market Cap

101.6M

ML Signal

HOLD

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

HOLD

Current Price

$1.44

Market Cap

81.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCOR
OKYO
Founded
1999
2007
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.6M
81.3M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
SCOR
OKYO
Price
$7.51
$1.44
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.33
AVG Volume (30 Days)
34.4K
91.3K
Earning Date
05-05-2026
07-18-2025
Dividend Yield
N/A
N/A
EPS Growth
127.37
N/A
EPS
N/A
N/A
Revenue
$403,549,000.00
N/A
Revenue This Year
$2.75
N/A
Revenue Next Year
$7.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.02
N/A
52 Week Low
$4.81
$1.34
52 Week High
$10.18
$3.35

Technical Indicators

Market Signals
Indicator
SCOR
OKYO
Relative Strength Index (RSI) 50.75 43.34
Support Level $6.97 N/A
Resistance Level $7.73 $1.72
Average True Range (ATR) 0.36 0.12
MACD 0.03 -0.02
Stochastic Oscillator 54.90 21.55

Price Performance

Historical Comparison
SCOR
OKYO

About SCOR comScore Inc.

comScore Inc is a information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. It create products using a data platform that combines information on digital platforms (connected televisions, mobile devices, tablets and computers), televisions, direct to consumer applications, and movie screens with demographics and other descriptive information. The company has developed proprietary data science that enables measurement of person-level and household-level audiences, removing duplicated viewing across devices and over time. Its segments include Content & Ad Measurement and Research & Insight Solutions of which the Content & Ad Measurement segment derives the majority of the revenue.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Share on Social Networks: